Fertility and Infertility Research News Portal

DUBLIN, July 14, 2021--(BUSINESS WIRE)--The "North America Infertility Testing and Treatment Market 2021-2028" report has been added to ResearchAndMarkets.com's offering.

North America infertility testing and treatment market is anticipated to garner a CAGR of 10.00% through the years 2021-2028. The United States and Canada together form the market in this region.

The studied market's growth in Canada is owing to multiple factors, such as rising cases of STDs and a surge in obesity levels. Moreover, as per estimates, the infertility count is growing at a rapid pace across the country, influencing the need for infertility treatments.

Furthermore, the supportive government measures to encourage infertility treatment, in addition to growing awareness about these treatments, are creating new opportunities for fertility clinics. For instance, the LIFE program was the first program introduced for treating infertility using in-vitro fertilization (IVF). Thus, such development indicates a robust growth of the infertility testing and treatment market within Canada.

The increasing number of infertility cases in the United States, on account of the rising middle-age pregnancies and the declining fertility rates, primarily fuel the country's infertility testing and treatment market growth.

In addition, as a widely utilized treatment, it enables and assists single mothers, couples with infertility issues, as well as the LGBT community to procreate. Furthermore, factors such as the augmenting trend of delayed pregnancies, the growth in disposable income, and the surge in IVF success rates are expected to play a vital role in facilitating the demand for infertility testing and treatment in the United States.

COMPETITIVE OUTLOOK

The key companies in the infertility testing and treatment market are Create Fertility Centre, Fujifilm Irvine Scientific, Progyny, Olympus Corporation, Genea Ltd, Labotect GmbH, and Ferring Pharmaceuticals.

Story continues

Key Topics Covered:

1. North America Infertility Testing and Treatment Market - Summary

2. Industry Outlook

2.1. Key Insights

2.1.1. Growing Demand for Low-Cost Procedures

2.1.2. Increasing Acceptance of Donor Eggs

2.1.3. Use of Ai Increases the Success of Ivf Treatment

2.2. Impact of COVID-19 on Infertility Testing and Treatment Market

2.3. Porter's Five Forces Analysis

2.4. Key Buying Impact Analysis

2.4.1. Treatment Options

2.4.2. Quality of Medical Procedures

2.4.3. Price of Treatments

2.4.4. Shift Towards Medical Tourism

2.4.5. Reimbursement

2.5. Market Attractiveness Matrix

2.6. Industry Components

2.7. Vendor Scorecard

2.8. Key Market Strategies

2.8.1. Contracts & Partnerships

2.8.2. Acquisitions & Mergers

2.8.3. New Product Launches

2.9. Market Drivers

2.9.1. Growth in Stress and Lifestyle Disorders

2.9.2. Rising Trend in Delayed Marriages and Pregnancies

2.9.3. Improvements in Treatments

2.9.4. Government Support

2.10. Market Challenges

2.10.1. High Cost

2.10.2. Social Taboo Pertaining to Infertility

2.10.3. Risks Associated With Treatments

2.11. Market Opportunities

2.11.1. Technology Advancements in Time-Lapse Technology

2.11.2. Advances in Embryo Biopsy and Genetic Screening

3. North America Infertility Testing and Treatment Market - by Gender

3.1. Male

3.1.1. Male Infertility Testing

3.1.1.1. Dna Fragmentation

3.1.1.2. Oxidative Stress Analysis

3.1.1.3. Sperm Penetration Assay

3.1.1.4. Computer-Assisted Semen Analysis (Casa)

3.1.1.5. Sperm Agglutination

3.1.1.6. Microscopic Examination

3.1.1.7. Others

3.1.2. Male Infertility Treatment

3.1.2.1. Medication

3.1.2.2. Assisted Reproductive Technology & Varicocele Surgery

3.2. Female

3.2.1. Female Infertility Testing

3.2.1.1. Ovulation Testing

3.2.1.2. Hysterosalpingography

3.2.1.3. Laparoscopy

3.2.1.4. Transvaginal Ultrasound

3.2.1.5. Ovarian Reserve Testing

3.2.1.6. Hormonal Level Testing

3.2.1.7. Others

3.2.2. Female Infertility Treatment

3.2.2.1. Ivf With Icsi

3.2.2.2. Iui

3.2.2.3. Ivf Without Icsi

3.2.2.4. Surrogacy

3.2.2.5. Thers

4. North America Infertility Testing and Treatment Market - by End-User

4.1. Fertility and Surgical Centers

4.2. Hospitals & Research Laboratories

4.3. Cryobanks

5. North America Infertility Testing and Treatment Market - Regional Outlook

5.1. United States

5.2. Canada

6. Competitive Landscape

6.1. Adorfem

6.2. Bangkok Ivf Center

6.3. Cook Medical Inc

6.4. Cooper Surgical

6.5. Create Fertility Centre

6.6. Emd Group (Merck Kgaa)

6.7. Endo International plc

6.8. Ferring Pharmaceuticals

6.9. Halotech Dna

6.10. Genea Ltd

6.11. Fujifilm Irvine Scientific

6.12. Vitrolife Ab

6.13. Labotect GmbH

6.14. Olympus Corporation

6.15. Progyny

For more information about this report visit https://www.researchandmarkets.com/r/65nj84

View source version on businesswire.com: https://www.businesswire.com/news/home/20210714005457/en/

Contacts

ResearchAndMarkets.comLaura Wood, Senior Press Managerpress@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900

See the article here:
North America Infertility Testing and Treatment Market Report 2021-2028: Technology Advancements in Time-Lapse Technology & Advances in Embryo...